Solasia Pharma K.K. (4597.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.89B |
| Enterprise Value | 5.66B |
| P/E Ratio | -9.61 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 22.52 |
| Price/Book Ratio | 6.02 |
| Enterprise/Revenue | 19.39 |
| Enterprise/EBITDA | -8.8 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.32 |
| Operating Margin | -2.3 |
AD
Management Effectiveness
| Return On Assets | -0.47 |
| Return On Equity | -0.54 |
Income Statement
| Revenue | 429M |
| Revenue/Share | 1.42 |
| Gross Profit | 171M |
| EBITDA | -822M |
| Net Income | -876M |
| Diluted EPS | -3.69 |
Balance Sheet
| Total Cash | 1.29B |
| Total Cash/Share | 4.72 |
| Total Debt | 78M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 4.28 |
| Book Value Per Share | 5.33 |
Price History
| 52-Week Change | -15.79 |
| 52-Week High | 42 |
| 52-Week Low | 21 |
| Moving Average 50 Days | 27.4 |
| Moving Average 200 Days | 29.98 |
Statistics
| Average Volume | 73.43M |
| Shares Outstanding | 273.01M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
